U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H12O7
Molecular Weight 316.2623
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISORHAMNETIN

SMILES

COC1=C(O)C=CC(=C1)C2=C(O)C(=O)C3=C(O2)C=C(O)C=C3O

InChI

InChIKey=IZQSVPBOUDKVDZ-UHFFFAOYSA-N
InChI=1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3

HIDE SMILES / InChI

Molecular Formula C16H12O7
Molecular Weight 316.2623
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Isorhamnetin, a flavonol aglycone, isolated from the traditional Chinese medicine H. rhamnoides L., was frequently used in traditional medicine to prevent and treat diverse diseases. Isorhamnetin has been shown to play a variety of roles in anti-oxidation, anti-inflammation, anti-tumor, anti-viral, and neurodegenerative injury protection. Isorhamnetin could inhibit the H2O2-induced activation of the intrinsic apoptotic pathway by scavenging free ROS and extracellular signal-regulated kinase 1/2 (ERK1/2) inactivation. In the type 2 diabetic rat model, isorhamnetin was found to be able to inhibit the NF-κB signaling activity, attenuate oxidative stress, and decrease the production of inflammatory mediators. Isorhamnetin can suppress skin cancer, breast cancer, colon cancer and atherosclerosis by inhibiting PI3K/AKT activation. Isorhamnetin shows inhibitory activity toward CYP1B1 expression and function.

Originator

Sources: DOI: 10.1021/ja02229a015
Curator's Comment: glucoside

Approval Year

PubMed

PubMed

TitleDatePubMed
Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography.
2005-09-01
The influence of Calendulae officinalis flos extracts on cell cultures, and the chromatographic analysis of extracts.
2005-06-15
Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides.
2005-06
Total flavones of Hippophae rhamnoides promotes early restoration of ultimate stress of healing patellar tendon in a rat model.
2005-05
Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells.
2005-05
Flavonol glucoside profile of southern Italian red onion (Allium cepa L.).
2005-04-06
The simultaneous determination of selected flavonol glycosides and aglycones in Ginkgo biloba oral dosage forms by high-performance liquid chromatography-electrospray ionisation-mass spectrometry.
2005-04-01
Antiinflammatory constituents from the roots of Smilax bockii warb.
2005-04
Quercetin metabolism in vital and apoptotic human leukaemia cells.
2005-03
Synergistic effects of flavonoids and ascorbate on enhancement in DNA degradation induced by a bleomycin-Fe complex.
2005-03
Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
2005-02-18
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
2005-02-15
Inhibitory activity of isorhamnetin from Persicaria thunbergii on Farnesyl Protein Transferase.
2005-02
[Applications of two-dimensional liquid chromatography coupled to mass spectrometry for the separation and identification of compounds in ginkgo biloba extracts].
2005-01
Oleanane triterpenes from Aegiceras corniculatum.
2005-01
Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
2005
Molecular characterization and functional expression of flavonol 6-hydroxylase.
2004-12-13
Cytoprotection by neutral fraction of tannat red wine against oxidative stress-induced cell death.
2004-12-01
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans.
2004-12
The protozoan Tetrahymena as a bioindicator to screen bioactive substances.
2004-11
Characterisation of flavonols in broccoli (Brassica oleracea L. var. italica) by liquid chromatography-uV diode-array detection-electrospray ionisation mass spectrometry.
2004-10-29
High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
2004-09-24
Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity.
2004-09-13
Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
2004-07-14
Structural investigations of flavonol glycosides from sea buckthorn (Hippophaë rhamnoides) pomace by NMR spectroscopy and HPLC-ESI-MS(n).
2004-06-30
Structural requirements of flavonoids for increment of ocular blood flow in the rabbit and retinal function recovery in rat eyes.
2004-06
Phytochemical analysis of ethyl acetate extract from Astragalus corniculatus Bieb. and brain antihypoxic activity.
2004-06
Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults.
2004-06
The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
2004-06
Urinary excretion of flavonoids reflects even small changes in the dietary intake of fruits and vegetables.
2004-05
Protective effects of quercetin and its metabolites on H2O2-induced chromosomal damage to WIL2-NS cells.
2004-02
Chemical taxonomy of the Xibei tree peony from China by floral pigmentation.
2004-02
Estrogenic activities of Ginkgo biloba extracts.
2004-01-30
[Studies on the flavonoid compounds of Rhododendron anthopogonoides].
2004-01
Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
2004-01
[Glucuronidation and in vitro interaction of Ginkgo flavonoids with other drugs].
2004-01
Isotamarixen - a new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida.
2004-01
Phenols and flavonoids in Aleppo pine needles as bioindicators of air pollution.
2003-12-17
[Ginkgo flavones in in vitro metabolism and its clinical application].
2003-12
Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats.
2003-12
Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneously hypertensive rats.
2003-11
Bioactive phenolics from Carthamus lanatus L.
2003-10-28
Flavonoid intake and breast cancer risk: a case--control study in Greece.
2003-10-06
Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids.
2003-10
Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102.
2003-09-09
Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) mill. Fruit juice: antioxidant and antiulcerogenic activity.
2003-08-13
Structure-antioxidant efficiency relationships of phenolic compounds and their contribution to the antioxidant activity of sea buckthorn juice.
2003-07-16
Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages.
2003-06-15
[Studies on chemical constituents of Cuscuta chinensis].
2002-02
The role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brain.
1992
Patents

Sample Use Guides

Mice: 100 mg/kg/day for 8 weeks
Route of Administration: Oral
Isorhamnetin (3-O-methyl quercetin) had no effect on human neuroblastoma SH-SY5Y cells viability even at 100 uM and even in presence of 500 uM ascorbic acid
Substance Class Chemical
Created
by admin
on Wed Apr 02 18:09:45 GMT 2025
Edited
by admin
on Wed Apr 02 18:09:45 GMT 2025
Record UNII
07X3IB4R4Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ISORHAMNETIN
INCI   USP-RS  
INCI  
Official Name English
3'-O-METHYLQUERCETIN
Preferred Name English
3,4',5,7-TETRAHYDROXY-3'-METHOXYFLAVONE
Systematic Name English
METHYLQUERCETIN, 3'-O-
Common Name English
ISORHAMNETIN (CONSTITUENT OF GINKGO) [DSC]
Common Name English
ISORHAMNETIN [USP-RS]
Common Name English
3,5,7-TRIHYDROXY-2-(4-HYDROXY-3-METHOXYPHENYL)-4-BENZOPYRONE
Systematic Name English
FLAVONE, 3,4',5,7-TETRAHYDROXY-3'-METHOXY-
Systematic Name English
4H-1-BENZOPYRAN-4-ONE, 3,5,7-TRIHYDROXY-2-(4-HYDROXY-3-METHOXYPHENYL)-
Systematic Name English
C.I. 75680
Common Name English
QUERCETIN 3'-METHYL ETHER
Common Name English
Code System Code Type Description
PUBCHEM
5281654
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
RS_ITEM_NUM
1351800
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-545-5
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
WIKIPEDIA
ISORHAMNETIN
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
CHEBI
6052
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
CHEBI
144055
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
FDA UNII
07X3IB4R4Z
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
EPA CompTox
DTXSID10197379
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
CAS
480-19-3
Created by admin on Wed Apr 02 18:09:45 GMT 2025 , Edited by admin on Wed Apr 02 18:09:45 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT
PARENT -> CONSTITUENT ALWAYS PRESENT